Protein Structure Facilitates High-Resolution Immunological Mapping. Clin Vaccine Immunol 2017 Dec;24(12)
Date
10/20/2017Pubmed ID
29046310Pubmed Central ID
PMC5717179DOI
10.1128/CVI.00275-17Scopus ID
2-s2.0-85040041257 (requires institutional sign-in at Scopus site) 1 CitationAbstract
Select agents (SA) pose unique challenges for licensing vaccines and therapies. In the case of toxin-mediated diseases, HHS assigns guidelines for SA use, oversees vaccine and therapy development, and approves animal models and approaches to identify mechanisms for toxin neutralization. In this commentary, we discuss next-generation vaccines and therapies against ricin toxin and botulinum toxin, which are regulated SA toxins that utilize structure-based approaches for countermeasures to guide rapid response to future biothreats.
Author List
Zuverink M, Barbieri JTAuthor
Joseph T. Barbieri PhD Professor in the Microbiology and Immunology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AnimalsBotulinum Toxins
Botulism
Crystallography, X-Ray
Humans
Models, Molecular
Poisoning
Protein Conformation
Ricin
Vaccines









